Medical and Pharmaceutical Nuvation Bio stock climbs 16.67% on FDA approval of lung cancer drug The approval marked a pivotal milestone for the company, transitioning it from a clinical-stage entity to a commercial-stage player Joseph Morton6 days ago
AI and Autonomy Moffitt adopts PathAI AISight Dx to drive cancer care innovation The partnership establishes a framework for joint research initiatives, real-world data collection, and clinical trial support Joseph MortonAugust 27, 2025
Medical and Pharmaceutical CG Oncology shares jump on positive clinical trial data for cancer drug The U.S. Food and Drug Administration (FDA) granted cretostimogene Fast Track and Breakthrough Therapy designations Joseph MortonApril 28, 2025